Takeda exec jumps ship to join Biogen

4 December 2017
biogen-big-1

US biotech major Biogen (Nasdaq: BIIB) has appointed Mark Hernon as senior vice president, chief information officer, effective December 4.

Mr Hernon joins Biogen with more than 30 years of experience in information technology (IT) and strategic leadership. In recent years with Takeda Pharmaceutical, he was the regional CIO for the Americas and global head of R&D, QA and HR Systems, as well as VP of operations for the Cambridge, MA site. He was most recently the global head of R&D site strategy and operations, where he led the global transformation of Takeda’s R&D footprint.

In his new role at Biogen, Mr Hernon will lead the global IT organization and be responsible for accelerating and supporting Biogen’s operations through delivery of innovative technology capabilities, systems, and tools that align with Biogen’s corporate strategy.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology